BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31445164)

  • 1. HAP1 is an in vivo UBE3A target that augments autophagy in a mouse model of Angelman syndrome.
    Wang T; Wang J; Wang J; Mao L; Tang B; Vanderklish PW; Liao X; Xiong ZQ; Liao L
    Neurobiol Dis; 2019 Dec; 132():104585. PubMed ID: 31445164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult
    Rotaru DC; van Woerden GM; Wallaard I; Elgersma Y
    J Neurosci; 2018 Sep; 38(37):8011-8030. PubMed ID: 30082419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Nociception in Angelman Syndrome Model Mice.
    McCoy ES; Taylor-Blake B; Aita M; Simon JM; Philpot BD; Zylka MJ
    J Neurosci; 2017 Oct; 37(42):10230-10239. PubMed ID: 28931574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards a therapy for Angelman syndrome by targeting a long non-coding RNA.
    Meng L; Ward AJ; Chun S; Bennett CF; Beaudet AL; Rigo F
    Nature; 2015 Feb; 518(7539):409-12. PubMed ID: 25470045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology.
    Dindot SV; Antalffy BA; Bhattacharjee MB; Beaudet AL
    Hum Mol Genet; 2008 Jan; 17(1):111-8. PubMed ID: 17940072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome.
    Gustin RM; Bichell TJ; Bubser M; Daily J; Filonova I; Mrelashvili D; Deutch AY; Colbran RJ; Weeber EJ; Haas KF
    Neurobiol Dis; 2010 Sep; 39(3):283-91. PubMed ID: 20423730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards an understanding of Angelman syndrome in mice studies.
    Yang X
    J Neurosci Res; 2020 Jun; 98(6):1162-1173. PubMed ID: 31867793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Truncation of Ube3a-ATS unsilences paternal Ube3a and ameliorates behavioral defects in the Angelman syndrome mouse model.
    Meng L; Person RE; Huang W; Zhu PJ; Costa-Mattioli M; Beaudet AL
    PLoS Genet; 2013; 9(12):e1004039. PubMed ID: 24385930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal Loss of Ube3a Impairs Experience-Driven Dendritic Spine Maintenance in the Developing Visual Cortex.
    Kim H; Kunz PA; Mooney R; Philpot BD; Smith SL
    J Neurosci; 2016 Apr; 36(17):4888-94. PubMed ID: 27122043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward a Broader View of Ube3a in a Mouse Model of Angelman Syndrome: Expression in Brain, Spinal Cord, Sciatic Nerve and Glial Cells.
    Grier MD; Carson RP; Lagrange AH
    PLoS One; 2015; 10(4):e0124649. PubMed ID: 25894543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9 directed to the Ube3a antisense transcript improves Angelman syndrome phenotype in mice.
    Schmid RS; Deng X; Panikker P; Msackyi M; Breton C; Wilson JM
    J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33411694
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Wallace ML; van Woerden GM; Elgersma Y; Smith SL; Philpot BD
    J Neurophysiol; 2017 Jul; 118(1):634-646. PubMed ID: 28468997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of dopaminergic neurons and resulting behavioural deficits in mouse model of Angelman syndrome.
    Mulherkar SA; Jana NR
    Neurobiol Dis; 2010 Dec; 40(3):586-92. PubMed ID: 20696245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent neuronal Ube3a expression in the suprachiasmatic nucleus of Angelman syndrome model mice.
    Jones KA; Han JE; DeBruyne JP; Philpot BD
    Sci Rep; 2016 Jun; 6():28238. PubMed ID: 27306933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide gene expression profiling of the Angelman syndrome mice with Ube3a mutation.
    Low D; Chen KS
    Eur J Hum Genet; 2010 Nov; 18(11):1228-35. PubMed ID: 20571502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UBE3A regulates the transcription of IRF, an antiviral immunity.
    Furumai R; Tamada K; Liu X; Takumi T
    Hum Mol Genet; 2019 Jun; 28(12):1947-1958. PubMed ID: 30690483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the requirements of prenatal UBE3A expression for rescue of behavioral phenotypes in a mouse model for Angelman syndrome.
    Sonzogni M; Zhai P; Mientjes EJ; van Woerden GM; Elgersma Y
    Mol Autism; 2020 Sep; 11(1):70. PubMed ID: 32948244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rescue of altered HDAC activity recovers behavioural abnormalities in a mouse model of Angelman syndrome.
    Jamal I; Kumar V; Vatsa N; Shekhar S; Singh BK; Sharma A; Jana NR
    Neurobiol Dis; 2017 Sep; 105():99-108. PubMed ID: 28576709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abundance and localization of human UBE3A protein isoforms.
    Sirois CL; Bloom JE; Fink JJ; Gorka D; Keller S; Germain ND; Levine ES; Chamberlain SJ
    Hum Mol Genet; 2020 Nov; 29(18):3021-3031. PubMed ID: 32833011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imprinting effects of UBE3A loss on synaptic gene networks and Wnt signaling pathways.
    Lopez SJ; Laufer BI; Beitnere U; Berg EL; Silverman JL; O'Geen H; Segal DJ; LaSalle JM
    Hum Mol Genet; 2019 Nov; 28(22):3842-3852. PubMed ID: 31625566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.